DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Electronic Health Record Strategies to Promote Diverse Participation in Research

Not Applicable

Completed

Conditions: Patient Participation

Interventions: Other: Traditional Letter
Other: Banner
Other: Direct to Patient Message
Other: Chatbot

First Posted Date: 2022-04-27

Last Posted Date: 2023-12-11

Lead Sponsor: Yale University

Target Recruit Count: 726199

Registration Number: NCT05348603

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Promoting Alcohol Treatment Engagement Post-hospitalization

Not Applicable

Recruiting

Conditions: Alcohol Use Disorder

Interventions: Behavioral: Brief Negotiated Interview (BNI)
Behavioral: BNI+facilitated provision of MAUD
Behavioral: Brief Negotiated Interview BNI+facilitated provision of MAUD+CBT4CBT

First Posted Date: 2022-04-21

Last Posted Date: 2025-04-25

Lead Sponsor: Yale University

Target Recruit Count: 450

Registration Number: NCT05338151

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

An AI-based mHealth Intervention to Improve HIV Testing

Not Applicable

Recruiting

Conditions: HIV Infections

Interventions: Behavioral: An AI-chatbot-based mHealth intervention
Behavioral: An attention-chatbot-based mHealth intervention
Behavioral: Educational materials

First Posted Date: 2022-04-19

Last Posted Date: 2025-01-03

Lead Sponsor: Yale University

Target Recruit Count: 296

Registration Number: NCT05335096

Locations: 🇲🇾
University of Malaysia, Kuala Lumpur, Malaysia

Pain Care at Home to Amplify Function (Pain CHAMP)

Not Applicable

Recruiting

Conditions: Chronic Pain
Opioid Use Disorder
Opioid Misuse

Interventions: Behavioral: TCM
Behavioral: TCM plus COPES

First Posted Date: 2022-04-19

Last Posted Date: 2024-07-03

Lead Sponsor: Yale University

Target Recruit Count: 540

Registration Number: NCT05333341

Locations: 🇺🇸
Little Rock VAMC, Little Rock, Arkansas, United States
🇺🇸
Eastern Colorado HCS, Aurora, Colorado, United States
🇺🇸
VA Connecticut HCS, West Haven, Connecticut, United States

Developing e-Covery, an App-based Intervention to Support Individuals With Co-occurring Problem Alcohol and Opioid Use

Not Applicable

Completed

Conditions: Alcohol Use Disorder
Opioid Use Disorder

Interventions: Other: e-Covery
Other: Comparator Condition

First Posted Date: 2022-04-13

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT05325788

Locations: 🇺🇸
ENRICH Lab, New Haven, Connecticut, United States

Mechanisms of Diuretic Resistance in Heart Failure, Aim 1

Phase 1

Recruiting

Conditions: Heart Failure

Interventions: Drug: Bumetanide Injection

First Posted Date: 2022-04-12

Last Posted Date: 2025-01-13

Lead Sponsor: Yale University

Target Recruit Count: 75

Registration Number: NCT05323487

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

Early Phase 1

Recruiting

Conditions: Hypoglycemia Unawareness
Diabetes Mellitus, Type 1

Interventions: Drug: Dichloroacetate

First Posted Date: 2022-04-07

Last Posted Date: 2025-05-01

Lead Sponsor: Yale University

Target Recruit Count: 16

Registration Number: NCT05317455

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms

Not Applicable

Completed

Conditions: Major Depressive Disorder
Mood Disorders
Bipolar Disorder
Suicide
Suicidal Ideation

Interventions: Behavioral: psychoeducational control comparator condition (CC)
Behavioral: BE-SMART-DR

First Posted Date: 2022-04-07

Last Posted Date: 2025-04-27

Lead Sponsor: Yale University

Target Recruit Count: 65

Registration Number: NCT05317481

Locations: 🇺🇸
Magnetic Resonance Research Center, New Haven, Connecticut, United States
🇺🇸
Mood Disorders Research Program, New Haven, Connecticut, United States

Pembrolizumab and Brentuximab Vedotin in Subjects with Relapsed/Refractory T-cell Lymphoma

Phase 2

Recruiting

Conditions: T-Cell Lymphoma

Interventions: Drug: Brentuximab vedotin
Drug: Pembrolizumab

First Posted Date: 2022-04-06

Last Posted Date: 2025-03-20

Lead Sponsor: Yale University

Target Recruit Count: 32

Registration Number: NCT05313243

Locations: 🇺🇸
Yale Smilow Cancer Hospital, New Haven, Connecticut, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis

Phase 2

Recruiting

Conditions: Idiopathic Subglottic Stenosis

Interventions: Drug: Taltz

First Posted Date: 2022-04-04

Last Posted Date: 2025-02-25

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT05309616

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy